top of page
CANN
About Us
Blog
Co-Infection Watch
Events
Groups
Partners
More...
Use tab to navigate through the menu items.
Search
Contact
Latest News
All Posts
Health System Consolidation
Healthcare Access & Affordability
Substance Use & Harm Reduction
Policy Commentary
Viral Hepatitis Policy
Treatment Access
Resources
Healthcare AI & Technology
Healthcare Policy Initiative
Legislative Tracking
HIV Prevention & PrEP
Regulatory Oversight
Rural Healthcare Access
Industry Impact Analysis
State Tracking
Telehealth & Digital Health
Treatment Access Issues
Regulatory Analysis
Overview
State Policy Tracking
Policy Implementation
Latest Updates
Multi-State Tracking
Blog
340B Drug Pricing Program
PBM Reform & Drug Pricing
Policy Analysis
Emerging Access Issues
HIV/AIDS Policy
Current Initiatives
Search
Novel Developments: Merck & Gilead Partner on New ARVs
Merck-Gilead partnership on long-acting injectables Islatravir and Lenacapavir for HIV treatment.
Jen Laws
Mar 28, 2021
3 min read
The Future is Now: Welcome to the Age of Injectables
FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.
Jen Laws
Feb 7, 2021
3 min read
We Need Your Support Today!
Donate
bottom of page
